[1]冉玉平,徐小茜,冉昕,等.伊曲康唑口服液治愈婴儿血管瘤1例:皮肤镜监测血管瘤消退情况[J].中国皮肤性病学杂志,2017,(01):45-47,49.[doi:10.13735/j.cjdv.1001-7089.201607074]
 RAN Yu-ping,XU Xiao-xi,RAN Xin,et al.A Case of Infantile Hemangioma Successfully Treated by Itraconazole Oral Solution: Dermoscopy Monitory the Vascular Regression[J].The Chinese Journal of Dermatovenereology,2017,(01):45-47,49.[doi:10.13735/j.cjdv.1001-7089.201607074]
点击复制

伊曲康唑口服液治愈婴儿血管瘤1例:皮肤镜监测血管瘤消退情况
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2017年01期
页码:
45-47,49
栏目:
临床经验
出版日期:
2017-01-20

文章信息/Info

Title:
A Case of Infantile Hemangioma Successfully Treated by Itraconazole Oral Solution: Dermoscopy Monitory the Vascular Regression
作者:
冉玉平徐小茜冉昕庄凯文陈爽穆潺冯孝伟孙凯奕唐教清杨琴
[作者单位] 四川大学华西医院皮肤性病科,四川 成都 610041
Author(s):
RAN Yu-ping XU Xiao-xi RAN Xin ZHUANG Kai-wen CHEN Shuang MU Chan FENG Xiao-wei SUN Kai-yi TANG Jiao-qing YANG Qin
Department of Dermatology, West China Hospital,Sichuan University, Chengdu 610041, China
关键词:
婴幼儿血管瘤 伊曲康唑口服液 噻吗洛尔 皮肤镜
Keywords:
Infantile hemangiomas Itraconazole oral solution Timolol Dermoscopy
分类号:
R 732.2
DOI:
10.13735/j.cjdv.1001-7089.201607074
文献标志码:
B
摘要:
患儿女,3个月,出生后第10天右腹部发现4个针尖大小红色丘疹,体积逐渐增加至6mm×4mm×1.6mm(彩超测定皮损体积),色鲜红,皮肤镜下可见线团块分布的血管网。予以马来酸噻吗洛尔滴眼液局部湿敷(2次/d,每次1小时,每次约0.5mL),3个多月后瘤体仍扩大融合并隆起,皮肤镜下血管网簇集成团,边缘可见向外延伸的血管分支,提示仍有扩大趋势。更改治疗为伊曲康唑口服液内服[5 mg/(kg·d)],治疗期间皮损颜色逐渐变暗,表面出现裂隙凹陷和皱纹,使之分成小叶状,皮肤镜下血管网变模糊,血管数量逐渐减少。治疗68天后(口服总量约2300 mg)临床及皮肤镜可观察到血管瘤有明显消退迹象遂停药随访。4月后血管瘤基本消退,残留少许纤维脂肪组织印迹。服药期间患儿肝肾功能在正常范围内,未见不适。伊曲康唑口服液治疗婴幼儿血管瘤服药方法简单方便,患儿及家属依从性好,治疗效果满意。皮肤镜在原位精准观察治疗过程血管瘤变化情况中起重要作用。
Abstract:
A 3-mouth girl presented with 4 little red dots on her abdomen 10 days after birth and the lesion kept growing to 6mm×4mm×1.6 mm(volume evaluated by color Doppler ultrasound performance).The lesion was brightly-red and linear and cloddy vascular network was seen under dermoscopy.Topical dressing of 0.5% timolol maleate eyedrop, 0.5 mL, 1 hours each time, twice a day was initial treatment.After 3 months of follow up, the lesion became bigger, dermoscopy observed more intensive vascular network and outward capillary branches which were the hints of growing trend.Administration of itraconazole oral solution was then altered for therapy with a dosage of 5 mg/kg/d.During the treatment, the lesion became darker, small cracks and wrinkles appeared on the surface which divided the lesion into lobules.Dermotoscopic feature showed instinct vascular network and less capillary branches.After 68 days of oral itraconazole solution(the total dose was about 2300 mg)the lesion was seen degrading obviously, then the treatment ended.The lesion was almost cured with little fibrofatty tissue left at the next 4 months of follow up.In the course of oral itraconazole, the patient's hepatic and renal function remained normal and no adverse react was observed.Itraconazole oral solution to treat infantile hemangioma was simple and easy to operate.The baby patient and parents showed good compliance and the clinical outcome demonstrated its efficacy.Dermotoscopy played a key role in vivo accurate observation of the hemangioma changes with vascular regression during the treatment process.

参考文献/References:

[1] Pope E, Chakkittakandiyil A.Topical timolol gel for infantile hemangiomas: a pilot study[J].Arch Dermatol, 2010,146(5):564-565.
[2] Ran Y, Chen S, Dai Y, et al.Successful treatment of oral itraconazole for infantile hemangiomas: a case series[J].J Dermatol, 2015,42(2):202-206.
[3] Williams H, Bigby M, Herxheimer A, et al(Eds.).Evidence-Based Dermatology 3rd Edition[M].John Wiley & Sons,2014:590-594.
[4] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al.Propranolol for severe hemangiomas of infancy[J].N Engl J Med, 2008,358(24):2649-2651.
[5] Painter SL, Hildebrand GD.Review of topical beta blockers as treatment for infantile hemangiomas[J].Surv Ophthalmol, 2016,61(1):51-58.
[6] Gupta AK, Cooper EA, Ginter G.Efficacy and safety of itraconazole use in children[J].Dermatol Clin, 2003,21(3):521-535.
[7] Zhang H, Ran Y, Li D, et al.Clavispora lusitaniae and Chaetomium atrobrunneum as rare agents of cutaneous infection[J].Mycopathologia, 2010,169(5):373-380.
[8] Chen S, Sun K, Feng X, et al.Efficacy and safety of itraconazole use in infants[J].World J Pediatr, 2016,12(4):399-407.
[9] Pantziarka P, Sukhatme V, Bouche G, et al.Repurposing drugs in oncology(ReDO)-itraconazole as an anti-cancer agent[J].Ecancermedicalscience, 2015,9:521-521.
[10]唐教清,陈爽,穆潺,等.伊曲康唑的非抗真菌作用研究进展[J].中华医学杂志,2016,96(30):2442-2445.
[11] Chong CR, Xu J, Lu J, et al.Inhibition of angiogenesis by the antifungal drug itraconazole[J].ACS Chem Biol, 2007,2(4):263-270.
[12] Nacev BA, Grassi P, Dell A, et al.The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2(VEGFR2)glycosylation, trafficking, and signaling in endothelial cells[J].J Biol Chem, 2011,286(51):44045-44056.
[13] Ran Y, Lu Y, Cao L, et al.Primary laryngeal aspergillosis related to oral sex A case report and review of the literature[J].Med Mycol Case Rep, 2012,2(1):1-3.
[14] Chang L, Ye X, Qiu Y, et al.Is propranolol safe and effective for outpatient use for infantile hemangioma A prospective study of 679 cases from one center in China[J].Ann Plast Surg, 2016,76(5):559-563.
[15] Sawa K, Yazdani A, Rieder MJ, et al.Propranolol therapy for infantile hemangioma is less toxic but longer in duration than corticosteroid therapy[J].Plast Surg(Oakv), 2014,22(4):233-236.

相似文献/References:

[1]罗亚楠,黄远红,冯雷,等.VEGF和DLL4在婴幼儿血管瘤组织中的表达及相关性[J].中国皮肤性病学杂志,2016,(03):225.[doi:10.13735/j.cjdv.1001-7089.201507039]
 LUO Ya nan,HUANG Yuan hong,FENG Lei,et al.Expression of VEGF and DLL4 in Infantile Hemangioma Tissue and Correlation of Them[J].The Chinese Journal of Dermatovenereology,2016,(01):225.[doi:10.13735/j.cjdv.1001-7089.201507039]
[2]王静,赵卓,王艳红,等.辽宁省婴幼儿血管瘤及其相关因素的Logistic回归分析[J].中国皮肤性病学杂志,2017,(06):619.[doi:10.13735/j.cjdv.1001-7089.201609068]
 WANG Jing,ZHAO Zhuo,WANG Yan-hong,et al.Unconditional Logistic Regression Analysis of Risk Factors for Infantile Hemangioma in Liaoning Province[J].The Chinese Journal of Dermatovenereology,2017,(01):619.[doi:10.13735/j.cjdv.1001-7089.201609068]
[3]张曌,陈欣玥,周念,等.婴幼儿血管瘤皮肤镜下特征[J].中国皮肤性病学杂志,2018,(01):33.[doi:10.13735/j.cjdv.1001-7089.201706106]
 ZHANG Zhao,CHEN Xinyue,ZHOU Nian,et al.Dermoscopic Features of Infantile Hemangioma[J].The Chinese Journal of Dermatovenereology,2018,(01):33.[doi:10.13735/j.cjdv.1001-7089.201706106]
[4]贺月华,冯雷,罗亚楠,等.EGFL7和FAK在婴幼儿血管瘤组织中的表达及其相关性[J].中国皮肤性病学杂志,2018,(06):620.[doi:10.13735/j.cjdv.1001-7089.201711097]
 HE Yuehua,FENG Lei,LUO Ya'nan,et al.Expression and Correlation of EGFL7 and FAK in Infantile Hemangioma[J].The Chinese Journal of Dermatovenereology,2018,(01):620.[doi:10.13735/j.cjdv.1001-7089.201711097]
[5]李鹏,李东繁,郭正团.普萘洛尔治疗婴幼儿血管瘤溃疡疗效观察[J].中国皮肤性病学杂志,2013,(02):149.
[6]龙玲珑,丁媛,向芳,等.普萘洛尔联合595 nm脉冲染料激光治疗婴幼儿血管瘤疗效观察[J].中国皮肤性病学杂志,2020,(02):165.[doi:10.13735/j.cjdv.1001-7089.201902098]
 LONG Linglong,DING Yuan,XIANG Fang,et al.Therapeutic Effect of Propranolol Combined with 595 nm Pulsed Dye Laser in the Treatment of Infantile Hemangiomas[J].The Chinese Journal of Dermatovenereology,2020,(01):165.[doi:10.13735/j.cjdv.1001-7089.201902098]

备注/Memo

备注/Memo:
[基金项目] 国家自然科学基金面上项目(81472539)
更新日期/Last Update: 2017-01-20